Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3

(2015) Elena Talero et al.   INFLAMMATORY BOWEL DISEASES

Vitamin K1 Exerts Antiproliferative Effects and Induces Apoptosis in Three Differently Graded Human Colon Cancer Cell Lines

(2015) Antonella Orlando et al.   Biomed Research International

Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis

(2015) Shuai Zhao et al.   PLoS One

Mesenchymal Stem Cells Cancel Azoxymethane-Induced Tumor Initiation

(2013) Masanao Nasuno et al.   STEM CELLS

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

(2013) Janelle C. Arthur et al.   Scientific Reports

Colorectal cancer in patients with inflammatory bowel disease: Can we predict risk?

(2012) Vibeke Andersen   WORLD JOURNAL OF GASTROENTEROLOGY

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy

(2010) Lixin Wang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Western-style diets induce macrophage infiltration and contribute to colitis-associated carcinogenesis

(2010) In-Wha Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

(2009) Jacqueline Bromberg et al.   CANCER CELL

gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

(2009) Julia Bollrath et al.   CANCER CELL

IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer

(2009) Sergei Grivennikov et al.   CANCER CELL

Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice

(2009) B. K. Popivanova et al.   CANCER RESEARCH

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis

(2009) Jon Brendan Wiggins et al.   Expert Opinion on Drug Metabolism & Toxicology

Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells

(2008) Yongpeng Gu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

(2008) Hien Q. Huynh et al.   INFLAMMATORY BOWEL DISEASES